Episode Breakdown01:00—History of DCRI: The roots of Duke’s Clinical Research Institute and the rise of population-scale cardiovascular trials.04:00—Meet Donna Parker: Donna’s journey from public health and pediatric trials to leading innovation as Director of i-Cubed at DCRI.05:00—Why i-Cubed? The founding vision to speed up, de-risk, and democratize clinical trials via novel partnerships and commercialization pathways.08:00—Entrepreneurship Inside Duke: The two “pipelines” for innovation—internal clinician/employee inventors, and industry/startup co-development.09:30—The i-Cubed Model: Support for entrepreneurs from idea validation to market fit, pricing, and brand development; EIR program details.15:00—Engaging Pharma and Industry: How traditional players partner with DCRI/i-Cubed for academic insight, validation, and AB testing.21:00—Macro-Level Shifts: The impact of COVID-19, remote and decentralized clinical trials, and the new frontiers opened by AI and data.25:00—AI in Clinical Research: From recruitment and protocol creation to governance and practical challenges; why trust and human connection still matter.Featured GuestsDonna Parker — Director, i-Cubed, Duke Clinical Research Institute (LinkedIn)Mamta Elias — Director, Alloy Partners (LinkedIn)Drew Beechler — VP Marketing, Alloy Partners (LinkedIn)Referenced in the ShowDuke Clinical Research Institute: dcri.orgi-Cubed Center: DCRI i-CubedDCRI Think Tank Program: Think Tanks at DCRIResources & Related LinksAlloy PartnersPartnership inquiries: [email protected] episodes of Advantaged: Alloy Partners PodcastFor more insights on corporate innovation and entrepreneurship in healthcare, subscribe to the Advantaged podcast and follow Alloy Partners on LinkedIn.
 Advantaged: An Alloy Partners Podcast

Ver todos los episodios